May 30, 2022
Chugai Pharmaceutical said on May 27 that the Tokyo District Court struck down its claim over the method-of-use patent of its osteoporosis treatment Edirol (eldecalcitol) in a lawsuit the company has brought against two major generic makers in Japan. The...read more